Providence Cancer Institute - Franz Clinic

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)	Advanced Non-small Cell Lung Cancer, HER2 Mutation	Recruiting	Phase 3	2026-09-23		NCT06452277
A Clinical Study of YL205 in Patients With Advanced Solid Tumors	Advanced Solid Tumors	Recruiting	Phase 1 / Phase 2	2025-12-23		NCT06459973

Clinical trials